India Education Diary on MSN
Complex bladder cancer surgery successfully performed at JNMCH, AMU
Aligarh, Jan. 30 -- Aligarh : In a major medical achievement, doctors at Jawaharlal Nehru Medical College and Hospital (JNMCH), Aligarh Muslim University (AMU), successfully performed a complex ...
While a record number of surgeries is being performed in the province, the number of people on Alberta's waitlist is longer than it was two years ago. And the latest provincial data shows less than ...
Bay County’s Advanced Urology Institute is being recognized as a center of excellence for treating overactive bladder and retention. Advanced Urology ...
Autopsy reveals man dies from sepsis after aluminium eyeliner, inserted autoerotically, penetrates rectum and forms giant bladder stone over 3 years.
Andrew Holtzhausen went from writing a matric maths exam to completing his finals from a hospital bed after emergency surgery ...
Risk Score Model of Aging-Related Genes for Bladder Cancer and Its Application in Clinical Prognosis
Bladder cancer ranks as the 10th most common malignancy worldwide, with rising incidence and mortality rates. Owing to its molecular and clinical heterogeneity, bladder cancer is associated with high ...
A Vancouver woman and her husband filed a lawsuit against Legacy Salmon Creek Medical Center and her physician over surgery complications. DeAndras and Ryan Macheras filed the complaint Dec. 11 in ...
MOUNT PLEASANT, S.C. (WCSC) — A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the lives of patients. A Lowcountry doctor has ...
The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate, as a perioperative neoadjuvant treatment and postcystectomy ...
An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results